 CELEBRATION, Fla., Sept. 01, 2022 GLOBE NEWSWIRE -- KemPharm, Inc. NasdaqGS: KMPH KemPharm, or the Company, a specialty pharmaceutical company focused on the discovery, development and commercialization of novel treatments for rare central nervous system CNS, neurodegenerative and lysosomal storage diseases, today announced that Travis C. Mickle, Ph.D., President and CEO of KemPharm, will deliver a virtual presentation at the H.C. Wainwright 24th Annual Global Investment Conference being held from September 12-14, 2022, in New York, New York. In addition, management will be available for virtual one-on-one investor meetings during the conference. 